Order Article Reprints

Lapshina MA, Shevtsova EF, Grigoriev VV, Aksinenko AY, Ustyugov AA, Steinberg DA, Maleev GV, Dubrovskaya ES, Goreva TV, Epishina TA, et al. New Adamantane-Containing Edaravone Conjugates as Potential Neuroprotective Agents for ALS Treatments. Molecules. 2023; 28(22):7567. https://doi.org/10.3390/molecules28227567

Lapshina, Maria A., Elena F. Shevtsova, Vladimir V. Grigoriev, Aleksey Yu. Aksinenko, Aleksey A. Ustyugov, Daniil A. Steinberg, Grigoriy V. Maleev, Elena S. Dubrovskaya, Tatiana V. Goreva, Tatiana A. Epishina, and et al. 2023. "New Adamantane-Containing Edaravone Conjugates as Potential Neuroprotective Agents for ALS Treatments" Molecules 28, no. 22: 7567. https://doi.org/10.3390/molecules28227567

Lapshina, M. A., Shevtsova, E. F., Grigoriev, V. V., Aksinenko, A. Y., Ustyugov, A. A., Steinberg, D. A., Maleev, G. V., Dubrovskaya, E. S., Goreva, T. V., Epishina, T. A., Zamoyski, V. L., Makhaeva, G. F., Fisenko, V. P., Veselov, I. M., Vinogradova, D. V., & Bachurin, S. O. (2023). New Adamantane-Containing Edaravone Conjugates as Potential Neuroprotective Agents for ALS Treatments. Molecules, 28(22), 7567. https://doi.org/10.3390/molecules28227567